June 2026– date –
-
Electrospun Nanofiber Humidity Sensors Outperform Commercial Counterparts with Sub-Second Response Time and >10^5 Response Ratio; Stability Improvement Key Challenge
RSC Publishing International Overview A review from RSC Publishing highlights that electrospun nanofiber-based humidity sensors demonstrate superior performance, significantly surpassing commercial alternatives. Leveraging the high surfa... -
Nanomedicine Shows Promise for Cardiovascular Inflammation Treatment, Yet Many Therapies Remain in Preclinical Stages
MDPI International Overview An MDPI review assesses nanomedicine's potential in cardiovascular inflammation diagnosis and treatment strategies. Nanoparticles (NPs) could offer advantages over conventional therapies through targeted drug ... -
FDA Decision on Nanocapsulated Sirolimus and Pegadricase Combination NASP for Gout Treatment Expected June 27, 2026
Prime Therapeutics - Portal USA Overview The U.S. FDA is scheduled to announce its decision on NASP (nanocapsulated sirolimus + pegadricase), a treatment for refractory gout, on June 27, 2026. NASP is an intravenous formulation combining... -
Empa Spin-Off Swiss Cluster Wins Swiss Economic Award for Hybrid PVD/ALD Coating Technology
Empa (Swiss Federal Laboratories for Materials Science and Technology) Switzerland Overview Swiss Cluster, an Empa spin-off, has won the Swiss Economic Award for its innovative hybrid PVD (Physical Vapor Deposition) and ALD (Atomic Layer... -
Electrospintek Delivers High-Performance Electrospinning Machines for Industry, Spanning Medical Wound Dressings to Battery Separators
Electrospintek International Overview Electrospintek offers high-performance electrospinning machines for diverse industrial applications, including medical wound dressings, filtration media, battery separators, and advanced textiles, to... -
The Reality of Nanotechnology in Drug Delivery: Low Target Accumulation and Urgent Need for Improved Testing Models Highlighted
IJPS Journal International Overview An IJPS Journal review critically examines the practical challenges of nanotechnology in drug delivery, emphasizing the persistently low rate of nanoparticle accumulation at target tumor sites. The art... -
Beam Therapeutics Secures FDA IND Clearance for Liver-Targeted LNP Formulation BEAM-304 as PKU Treatment, Phase 1/2 Trial Imminent
Business Wire / Nasdaq USA Overview Beam Therapeutics announced FDA Investigational New Drug (IND) clearance for BEAM-304, its lead candidate for Phenylketonuria (PKU). BEAM-304 is a liver-targeted lipid nanoparticle (LNP) formulated bas... -
Infrared and Silica-Gold Nanoparticle Combination Significantly Inhibits Breast Cancer Cell Proliferation via Plasmonic Photothermal Therapy In Vitro
ResearchGate International Overview A new in vitro study demonstrates that plasmonic photothermal therapy (PPTT), combining infrared (IR) waves with silica-gold nanoparticles (AuNPs), effectively inhibits breast cancer cell proliferation... -
Nanotech Breakthrough: Technion Unveils Drug-Free Nanoparticles to Suppress Triple-Negative Breast Cancer
The Times of Israel イスラエル Overview Researchers at the Technion-Israel Institute of Technology have engineered 'MPsomes,' novel drug-free nanoparticles that effectively suppress aggressive triple-negative breast cancer (TNBC) tumors ... -
Italian DeepTech X-nano Raises €3.7M for Methane-to-Graphite Pilot Plant
Startupbusiness イタリア Overview Italian DeepTech startup X-nano, an IIT spin-off, has secured €3.7 million in seed funding to establish a pilot plant for its non-catalytic methane pyrolysis technology. This investment aims to accelerat...
